Skip to main content
. Author manuscript; available in PMC: 2009 Jun 26.
Published in final edited form as: J Cell Biochem. 2004 Jan 1;91(1):26–35. doi: 10.1002/jcb.10675

Fig. 1.

Fig. 1

The relative abundance of α6β1 and α6β4 integrins in human prostate cancer progression. Normal, prostatic intraepithelial neoplasia (PIN) and invasive cancer have either a dominant integrin pair as indicated by the bold arrow or suppression of integrin expression as indicated by (X). The α6p variant can be present as α6pβ1 or α6pβ4.